Health Condition 1: K758- Other specified inflammatory liverdiseases
Conditions
Interventions
Intervention1: Qurs-e-Sumbul-ut-Teeb: 2 tablets orally to be taken with water twice daily for 12 weeks
Control Intervention1: NIL: NIL
Sponsors
Central Council for Research in Unani Medicine CCRUM New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 18 to 60 years of either gender. 2. Normal /Elevated ALT level. 3. Normal/Elevated GGT level 4. Patients who have given their informed consent and willingly agreed to participate in the clinical trial. 5. Diabetic patients with well-controlled blood sugar levels. 6. Patients with a BMI ranging from 19 to 35.
Exclusion criteria
Exclusion criteria: 1. Acute Hepatitis. 2. Pregnant and lactating mother. 3. Obese (BMI more than 35) 4. Severe debilitated any systemic diseased as; GIT, Respiratory, Cardiovascular, Genito-urinary and nervous system. 6. Patients with the range of BMI more than 19 and less than or equals to 35. 5. Intolerant to Therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The efficacy of the study drugs will be assessed on the basis of DSQ-CLD (Disease specific questionnaire with chronic liver diseases)Timepoint: At every 14 days for 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological & biochemical assessment for safety assessment i.e. CBC, LFT, KFT, Urine Routine & microscopic examinationTimepoint: At baseline and at the end of treatment i.e. 12 weeks | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed